Not a good buy right now for an impatient buyer: price is sitting on key support with bearish momentum (MACD worsening) and no proprietary buy signals.
Near-term bounce is possible because RSI is getting low and price is at S1, but the risk/reward is unattractive without confirmation; a breakdown would likely push toward 1.664 quickly.
Fundamentals show revenue growth and improving gross margin, but profitability collapsed (net income/EPS), so there’s no clear fundamental “floor” supporting an aggressive buy today.
Trend/Momentum: MACD histogram is negative (-0.0209) and expanding lower → bearish momentum is strengthening.
RSI: RSI(6) at 34.78 → weak/near-oversold territory but not a clear reversal signal yet.
Moving averages: converging MAs → consolidation, but currently resolving to the downside given MACD/price weakness.
Levels: Price ~1.775 is essentially at S1 (1.774). A clean break below S1 makes S2 (1.664) the next downside level.
Upside reference: Pivot 1.951 is the first meaningful reclaim level; R1 2.129 after that.
Pattern-based forward bias (from similar candlesticks): modestly positive expected drift (next day +0.68%, next week +3.68%, next month +3.13%), but this conflicts with current bearish momentum—needs confirmation via reclaiming pivot/holding support.
Positive Catalysts
Earnings catalyst upcoming: QDEC 2025 earnings on 2026-02-12 (pre-market) could re-rate the stock if profitability/guide improves.
Q3 2025 revenue growth (+10.95% YoY) and gross margin improvement (+25.43% YoY to 21.65%) show operational progress.
Price is at a major support (S1 ~1.774), which can attract short-term dip buyers if support holds.
Neutral/Negative Catalysts
No supportive sentiment triggers: hedge funds neutral, insiders neutral, and no recent news flow to change narrative.
Gross margin: 21.65%, +25.43% YoY (improved unit economics).
Net income: 0.4M, -100.88% YoY (profitability collapsed vs prior year).
EPS: ~0, -100% YoY (earnings power not currently supporting a buy-the-dip decision).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price-target change data provided, so a clear Wall Street bull-vs-bear read cannot be confirmed from the dataset.
With missing coverage signals, the actionable view is driven primarily by price action + fundamentals: improving revenue/margins but weak earnings quality and bearish momentum argue against buying immediately.
Wall Street analysts forecast ECX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ECX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 1.670
Low
0
Averages
0
High
0
0
Current: 1.670
Low
0
Averages
0
High
0
UBS
Nora Min
Strong Buy
Initiates
$3.2
AI Analysis
2025-02-11
Reason
UBS
Nora Min
Price Target
$3.2
AI Analysis
2025-02-11
Initiates
Strong Buy
Reason
UBS analyst Nora Min initiated coverage of Ecarx with a Buy rating and $3.20 price target. Ecarx is the third largest smart cockpit producer in China by sales volume, the analyst tells investors in a research note. The firm says that as Geely's largest smart cockpit provider, Ecarx looks well positioned to benefit from the company's supply chain consolidation. UBS believes the market underestimates Ecarx's revenue growth capability, and forecasts 52% annual earnings growth between 2026 and 2028.
